Search research articles
Contact Us
Filters
Showing results (141-150 of 193) with videos related to
Page
of 20
Sort By:
Oncotarget
|
October 21, 2017
Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells
Marina O Gomzikova, Margarita N Zhuravleva, Regina R Miftakhova, et al.
NPJ Breast Cancer
|
March 30, 2023
Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers
Mashael Algethami, Michael S Toss, Corinne L Woodcock, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 15, 2019
The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts
Mansour Alsaleem, Michael S Toss, Chitra Joseph, et al.
Oncogene
|
August 15, 2018
The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
Martuza Sarwar, Azharuddin Sajid Syed Khaja, Mohammed Aleskandarany, et al.
Oncogene
|
March 6, 2021
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
Reem Ali, Adel Alblihy, Islam M Miligy, et al.
The New Phytologist
|
May 16, 2017
Identification of factors required for m<sup>6</sup> A mRNA methylation in Arabidopsis reveals a role for the conserved E3 ubiquitin ligase HAKAI
Kamil Růžička, Mi Zhang, Ana Campilho, et al.
Frontiers in Cell and Developmental Biology
|
March 8, 2024
Modulation of the pre-metastatic bone niche: molecular changes mediated by bone-homing prostate cancer extracellular vesicles
Thomas J Brown, Catrin S Rutland, Katie K Choi, et al.
NPJ Precision Oncology
|
July 19, 2022
Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers
Adel Alblihy, Reem Ali, Mashael Algethami, et al.
NPJ Breast Cancer
|
November 16, 2021
Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers
Adel Alblihy, Ahmed Shoqafi, Michael S Toss, et al.
Theranostics
|
August 10, 2021
Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers
Reem Ali, Muslim Alabdullah, Mashael Algethami, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 193) with videos related to
Sort By:
Page
of 20
Oncotarget
|
October 21, 2017
Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells
Marina O Gomzikova, Margarita N Zhuravleva, Regina R Miftakhova, et al.
NPJ Breast Cancer
|
March 30, 2023
Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers
Mashael Algethami, Michael S Toss, Corinne L Woodcock, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 15, 2019
The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts
Mansour Alsaleem, Michael S Toss, Chitra Joseph, et al.
Oncogene
|
August 15, 2018
The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
Martuza Sarwar, Azharuddin Sajid Syed Khaja, Mohammed Aleskandarany, et al.
Oncogene
|
March 6, 2021
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
Reem Ali, Adel Alblihy, Islam M Miligy, et al.
The New Phytologist
|
May 16, 2017
Identification of factors required for m<sup>6</sup> A mRNA methylation in Arabidopsis reveals a role for the conserved E3 ubiquitin ligase HAKAI
Kamil Růžička, Mi Zhang, Ana Campilho, et al.
Frontiers in Cell and Developmental Biology
|
March 8, 2024
Modulation of the pre-metastatic bone niche: molecular changes mediated by bone-homing prostate cancer extracellular vesicles
Thomas J Brown, Catrin S Rutland, Katie K Choi, et al.
NPJ Precision Oncology
|
July 19, 2022
Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers
Adel Alblihy, Reem Ali, Mashael Algethami, et al.
NPJ Breast Cancer
|
November 16, 2021
Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers
Adel Alblihy, Ahmed Shoqafi, Michael S Toss, et al.
Theranostics
|
August 10, 2021
Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers
Reem Ali, Muslim Alabdullah, Mashael Algethami, et al.
Page
of 20